Clinical trials: Gambling Addiction
Pathological Gambling
Dopamine Responsivity in Gamblers
This study deals with how people decide between rewards of different value. The investigators want to understand how the brain's dopamine system impacts this kind of decision making.
- Trial name
- NCT02772978
- Testing
- Tolcapone
- Volunteers
- 19 people
- Sponsor
- University of California, San Francisco
Gambling
Drug Treatment for Pathologic Gambling Disorder
This study will establish the best dose of the drug naltrexone to treat patients with Pathological Gambling Disorder (PGD) and severe urge symptoms.
- Trial name
- NCT00053677
- Testing
- Naltrexone
- Where
- United States
- Volunteers
- 83 people, healthy volunteers welcome
- Sponsor
- University of Chicago
Pathological Gambling
Investigation of Naltrexone for Pathological Gambling
The investigators plan to investigate the safety, tolerability, and efficacy of the opioid antagonist naltrexone in Pathological Gambling.
- Trial name
- NCT01057862
- Testing
- Naltrexone
- Where
- 3 sites in United States
- Volunteers
- 9 people
- Sponsor
- Yale University
Pathological Gambling
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
To determine if: 1. pathological gambling is similar to psychostimulant addiction as reflected by parallel roles for D1 and D2 receptors in gambling and stimulant reinforcement. 2.
- Trial name
- HFDEX (NCT02203786)
- Testing
- Haloperidol, Fluphenazine, Dexedrine
- Where
- Canada
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Centre for Addiction and Mental Health
Pathological Gambling, Gambling Disorder
Milk Thistle in Pathological Gambling
The goal of the proposed study is to evaluate the efficacy and safety of silymarin in individuals with gambling disorder. The hypothesis to be tested is that silymarin will be more effective and well tolerated in subjects with…
- Trial name
- NCT02337634
- Testing
- Milk Thistle
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- University of Chicago
Pathological Gambling
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.
- Trial name
- NCT01215357
- Testing
- Ecopipam
- Where
- 4 sites in United States
- Volunteers
- 34 people
- Sponsor
- Emalex Biosciences Inc.
Pathological Gambling
Topiramate in the Treatment of Pathological Gambling
This study will assess the efficacy of topiramate in the treatment of pathological gambling. Pathological gambling (PG) is a debilitating disorder, generally leading to severe personal, familial, financial, social, and…
- Trial name
- NCT00245583
- Testing
- Topiramate
- Where
- United States
- Volunteers
- 42 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Pathological Gambling
Integrative Couple Treatment for Pathological Gambling
The aim of the study is to compare marital treatment to individual treatment for pathological gambling.
- Trial name
- ICT-PG (NCT02240485)
- Testing
- Integrative Couple Treatment for Pathological Gambling (ICT-PG), Usual individual/group treatment
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- Université du Québec à Trois-Rivières
Pathological Gambling
Memantine Treatment Study of Pathological Gambling
The goal of the proposed study is to evaluate the efficacy and safety of the drug memantine in individuals with pathological gambling (PG).
- Trial name
- NCT00585169
- Testing
- Memantine Hydrochloride
- Where
- 2 sites in United States
- Volunteers
- 29 people
- Sponsor
- Yale University
Pathological Gambling
Tolcapone Treatment of Pathological Gambling
The goal of the proposed study is to evaluate the efficacy and safety of tolcapone in pathological gambling.
- Trial name
- NCT00927563
- Testing
- Tolcapone
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- University of Chicago
Gambling Addiction, Gambling Disorder
The Effect of Self Stigma Tailored Cognitive Behavioral Therapy on Gambling Disorder
The goal of this clinical trial was to evaluate whether a cognitive behavioral therapy (CBT) program focused on self-stigma could help reduce both self-stigma and gambling disorder severity in adults diagnosed with gambling…
- Conditions
- Gambling Addiction, Gambling Disorder, Gambling Disorder Treatment, Stigma
- Trial name
- NCT06943963
- Testing
- Self Stigma Tailored Cognitive Behavioral Therapy on Gambling Disorder, standart pharmacotherapy, motivational intervention
- Where
- Turkey (Türkiye)
- Volunteers
- 26 people
- Sponsor
- Ege University
Impulse Control Disorder, Parkinson Disease
Naltrexone for Impulse Control Disorders in Parkinson's Disease
This study will evaluate the effectiveness of naltrexone in reducing ICD symptoms in Parkinson's disease patients taking a dopamine agonist.
- Trial name
- NCT01052831
- Testing
- Naltrexone
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Pennsylvania
Pathological Gambling
Acamprosate in the Treatment of Pathological Gambling
The purpose of this study is to see whether acamprosate (Campral) will curb the desire to gamble in people with pathological gambling disorder.
- Trial name
- NCT00571103
- Testing
- acamprosate
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- University of Iowa
Gambling, Tobacco Use Disorder
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
The objective of this application is to examine whether, given its mechanism of action, the dietary supplement, N-acetyl cysteine (NAC) will reduce both tobacco use and pathological gamblers (PG) symptoms in nicotine dependent…
- Trial name
- NCT00967005
- Testing
- N Acetyl Cysteine, Sugar Pill
- Where
- 2 sites in United States
- Volunteers
- 28 people
- Sponsor
- University of Chicago
Pathological Gambling
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
Research specific to women's gambling treatment needs is limited but suggests a critical need for women sensitive options and reduced barriers to access.
- Trial name
- NCT01743092
- Testing
- Webinar, Tutuorial workbook
- Where
- Canada
- Volunteers
- 59 people
- Sponsor
- Centre for Addiction and Mental Health